CL-82198
CAS No. 307002-71-7
CL-82198( —— )
Catalog No. M24236 CAS No. 307002-71-7
CL-82198 is a selective inhibitor of MMP-13 and it is a pharmacologic treatment for preventing osteoarthritis (OA) progression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 41 | In Stock |
|
| 5MG | 37 | In Stock |
|
| 10MG | 64 | In Stock |
|
| 25MG | 147 | In Stock |
|
| 50MG | 237 | In Stock |
|
| 100MG | 369 | In Stock |
|
| 200MG | 541 | In Stock |
|
| 500MG | 849 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCL-82198
-
NoteResearch use only, not for human use.
-
Brief DescriptionCL-82198 is a selective inhibitor of MMP-13 and it is a pharmacologic treatment for preventing osteoarthritis (OA) progression.
-
DescriptionCL-82198 is a selective inhibitor of MMP-13 and it is a pharmacologic treatment for preventing osteoarthritis (OA) progression. CL-82198 binds to the entire S1’ pocket of MMP-13, which is the basis for its selectivity towards MMP-13 and the lack of inhibitory activities against other MMPs.
-
In Vitro——
-
In VivoAnimal Model:10-week-old C57BL/6J mice (performed MLI surgery)Dosage:1, 5, 10 mg/kg body weight Administration:Intraperitoneal injection; every other day for 12 weeks Result:Prevented and decelerated MLI-induced osteoarthritis progression.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorMMP-13
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number307002-71-7
-
Formula Weight302.37
-
Molecular FormulaC17H22N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (330.72 mM; Need ultrasonic)
-
SMILESO=C(c1cc(cccc2)c2o1)NCCCCN1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rath T et al. Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration. Oncol Lett. 2011 May;2(3):483-488.
molnova catalog
related products
-
YH-306
YH-306 is a modulator of the FAK signaling pathway that acts by suppressing colorectal tumor growth and metastasis.
-
CTTHWGFTLC, CYCLIC
This cyclic CTT Gelatinase Inhibitor peptide is an inhibitor for matrix metalloproteinases (MMP)-2 and MMP-9. It is also called type IV collagenase or gelatinase. Gelatinases are potential targets of therapeutic intervention in cancer, and inhibitors of these enzymes can prevent tumor progression.
-
Rilpivirine HCl
Rilpivirine HCl (Rilpivirine hydrochloride) is a selective and potent non-nucleoside reverse transcriptase inhibitor (NNRTI) with antiviral activity that inhibits the HIV virus and can be used in the study of HIV infections.
Cart
sales@molnova.com